Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
39S ribosomal protein L24, mitochondrial (MRPL24) is a structural protein encoded by the nuclear MRPL24 gene and is incorporated into the large (39S) subunit of the mitochondrial ribosome (mitoribosome) in humans. It participates in mitochondrial protein synthesis by contributing to the structure and function of mitoribosomes, which differ from prokaryotic ribosomes in protein-to-rRNA composition and lack of 5S rRNA. MRPL24 is larger than its E. coli counterpart and is essential for the translation of mitochondrial-encoded proteins that are critical for oxidative phosphorylation and other mitochondrial functions[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 39S ribosomal protein L24, mitochondrial (MRPL24).